|[February 26, 2013]
Biomet to Present at 2013 Goldman Sachs Healthcare Leveraged Finance Conference
WARSAW, Ind. --(Business Wire)--
Biomet, Inc. announced today that it will be participating in the 2013
Goldman Sachs Healthcare & Leveraged Finance Conference in New York, New
York, on March 6, 2013 at 8:40 a.m. local time.
A link to the presentation will be available on Biomet's website at www.biomet.com>
in the Investor Section.
Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. Biomet's product portfolio
encompasses large joint reconstructive products, including orthopedic
joint replacement devices, and bone cements and accessories; sports
medicine, extremities and trauma products, including internal and
external orthopedic fixation devices; spine and bone healing products,
including spine hardware, spinal stimulation devices, and
orthobiologics, as well as electrical bone growth stimulators and
softgoods and bracing; dental reconstructive products; and other
products, including microfixation products and autologous therapies.
Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently
distribute products in approximately 90 countries
[ Sports Techy's Homepage ]